Inovio Pharma (INO) Swings to Q3 Profit
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.21 --0%
EPS Growth %: +75.9%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +75.9%
Financial Fact:
Loss from operations: -20.2M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q3 EPS of $0.07, versus ($0.12) reported last year. Revenue for the quarter came in at $24.18 million, versus $1.84 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Needham Reiterates Hold Rating on Envista Holdings Corp. (NVST)
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
